You Make the Call: Readers' Response

You Make the Call: Readers' Response

How readers responded to this month's You Make the Call question


Disclaimer: ASH does not recommend or endorse any specific tests, physicians, products, procedures, or opinions, and disclaims any representation, warranty, or guaranty as to the same. Reliance on any information provided in this article is solely at your own risk.

You Make the Call

Prescription for a patient with type 1 von Willebrand disease who is about to...

Here's how readers responded to a You Make the Call question about a patient with type 1 von Willebrand disease who is about to undergo...
You Make the Call

What to prescribe for a patient with newly diagnosed CML who lives outside of...

Here's how readers responded to a You Make the Call question about a patient with newly diagnosed CML who lives outside of the United States. Disclaimer:...
You Make the Call

Does this child have both beta and alpha thalassemia trait?

Here's how readers responded to a You Make the Call question about a diagnosis of beta and alpha thalassemia trait. Disclaimer: ASH does not recommend...
You Make the Call

How long should a multiple myeloma patient receive lenalidomide maintenance therapy?

Here's how readers responded to a You Make the Call question about lenalidomide maintenance in a patient with multiple myeloma. Disclaimer: ASH does not recommend...
You Make the Call

How would you treat a patient with Wilson’s disease and neutropenia?

Here's how readers responded to a You Make the Call question about a patient with Wilson’s disease and neutropenia? Disclaimer: ASH does not recommend or endorse...
Advertisement

Current Issue

June 2021 Volume 7 Issue 7

This issue reviews the management and prevention of peripheral neuropathy, early successes of SCD screening programs in sub-Saharan Africa, and more.

Block title